Cobenfy® (xanomeline and trospium chloride)
for Schizophrenia

Cobenfy (xanomeline and trospium chloride) is a treatment for schizophrenia that improves both positive and negative symptoms. It contains xanomeline, which activates muscarinic receptors (M1 and M4) in the brain to help manage schizophrenia, and trospium, which reduces side effects by blocking muscarinic receptors outside the brain.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Schizophrenia